GPR182 is an endothelium-specific atypical chemokine receptor that maintains hematopoietic stem cell homeostasis.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
27 04 2021
Historique:
entrez: 20 4 2021
pubmed: 21 4 2021
medline: 15 12 2021
Statut: ppublish

Résumé

G protein-coupled receptor 182 (GPR182) has been shown to be expressed in endothelial cells; however, its ligand and physiological role has remained elusive. We found GPR182 to be expressed in microvascular and lymphatic endothelial cells of most organs and to bind with nanomolar affinity the chemokines CXCL10, CXCL12, and CXCL13. In contrast to conventional chemokine receptors, binding of chemokines to GPR182 did not induce typical downstream signaling processes, including G

Identifiants

pubmed: 33875597
pii: 2021596118
doi: 10.1073/pnas.2021596118
pmc: PMC8092405
pii:
doi:

Substances chimiques

CXCL12 protein, human 0
CXCL13 protein, human 0
Chemokine CXCL10 0
Chemokine CXCL12 0
Chemokine CXCL13 0
Chemokines 0
GPR182 protein, human 0
Receptors, Chemokine 0
Receptors, G-Protein-Coupled 0
beta-Arrestins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

J Exp Med. 2006 Sep 4;203(9):2201-13
pubmed: 16940167
Nat Rev Immunol. 2013 Nov;13(11):815-29
pubmed: 24319779
Nat Immunol. 2014 Mar;15(3):207-8
pubmed: 24549061
Br J Pharmacol. 2015 Aug;172(16):3945-9
pubmed: 25958743
Genesis. 2000 Nov-Dec;28(3-4):106-10
pubmed: 11105051
Cell Stem Cell. 2007 Aug 16;1(2):204-17
pubmed: 18371351
J Biol Chem. 2012 Aug 17;287(34):28362-77
pubmed: 22736769
J Biol Chem. 2005 Oct 21;280(42):35760-6
pubmed: 16107333
Eur J Immunol. 1998 Nov;28(11):3696-705
pubmed: 9842912
Nat Commun. 2018 Jan 12;9(1):177
pubmed: 29330456
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7260-5
pubmed: 10860991
Mol Pharmacol. 2008 May;73(5):1362-70
pubmed: 18230715
Annu Rev Immunol. 2014;32:659-702
pubmed: 24655300
PLoS One. 2014 Jun 04;9(6):e98328
pubmed: 24896823
Immunology. 2010 Apr;129(4):536-46
pubmed: 20002784
Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G316-26
pubmed: 15358596
Oncogene. 2010 Aug 12;29(32):4599-610
pubmed: 20531309
Mol Pharmacol. 2018 Apr;93(4):251-258
pubmed: 29298813
Genesis. 2008 May;46(5):235-45
pubmed: 18442043
Cell Mol Immunol. 2018 Apr;15(4):324-334
pubmed: 29375126
Cytokine. 2016 Nov;87:37-45
pubmed: 27498604
Biochem Biophys Res Commun. 1998 Mar 27;244(3):832-7
pubmed: 9535752
Nature. 2013 Mar 14;495(7440):231-5
pubmed: 23434755
Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14759-64
pubmed: 17804806
Exp Cell Res. 2005 Oct 15;310(1):117-30
pubmed: 16125170
Cell. 2008 Oct 31;135(3):561-71
pubmed: 18984166
FASEB J. 2015 Nov;29(11):4497-511
pubmed: 26139098
J Biol Chem. 1995 Oct 27;270(43):25344-7
pubmed: 7592696
Front Immunol. 2016 Jun 10;7:224
pubmed: 27375622
ACS Pharmacol Transl Sci. 2020 Jun 24;3(4):676-689
pubmed: 32832870
Nat Rev Mol Cell Biol. 2019 May;20(5):303-320
pubmed: 30745579
Nature. 2013 Mar 14;495(7440):227-30
pubmed: 23434756
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):628-32
pubmed: 20018651
Nat Struct Mol Biol. 2015 May;22(5):362-9
pubmed: 25895059
J Biol Chem. 2013 Mar 8;288(10):7169-81
pubmed: 23341447
J Clin Invest. 2017 Feb 1;127(2):593-607
pubmed: 28094771
EMBO J. 1997 Dec 1;16(23):6996-7007
pubmed: 9384579
PLoS One. 2010 Feb 11;5(2):e9175
pubmed: 20161793
Blood. 2009 May 28;113(22):5680-8
pubmed: 19144989
Physiol Rev. 2005 Oct;85(4):1159-204
pubmed: 16183910
Cell. 2019 Jun 13;177(7):1933-1947.e25
pubmed: 31160049
Sci Signal. 2013 Apr 30;6(273):ra30.1-11, S1-3
pubmed: 23633677
Cell Death Dis. 2018 Feb 5;9(2):154
pubmed: 29402989
Cytokine. 2018 Sep;109:17-23
pubmed: 29903572
BMC Palliat Care. 2018 Feb 20;17(1):32
pubmed: 29463240
Mol Pharmacol. 2019 Dec;96(6):809-818
pubmed: 31040166
Biochem Pharmacol. 2018 Jul;153:62-74
pubmed: 29454621
Nat Rev Immunol. 2017 Sep;17(9):573-590
pubmed: 28604734
J Biol Chem. 2004 Jun 11;279(24):25590-7
pubmed: 15084596
FASEB J. 2012 Dec;26(12):4841-54
pubmed: 22913878
FEBS J. 2018 Aug;285(16):2944-2971
pubmed: 29637711
Br J Pharmacol. 2019 Dec;176 Suppl 1:S21-S141
pubmed: 31710717
J Biol Chem. 2008 Mar 21;283(12):7972-82
pubmed: 18201974
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
J Exp Med. 1997 Jan 6;185(1):111-20
pubmed: 8996247
Blood. 2005 Jul 15;106(2):534-41
pubmed: 15802528
Sci Adv. 2019 Sep 18;5(9):eaaw2778
pubmed: 31555726
Angiogenesis. 2014 Jul;17(3):511-8
pubmed: 24257808
Cell Stem Cell. 2019 Dec 5;25(6):846-854.e4
pubmed: 31809740

Auteurs

Alan Le Mercier (A)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany.

Remy Bonnavion (R)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany; remy.bonnavion@mpi-bn.mpg.de Stefan.Offermanns@mpi-bn.mpg.de.

Weijia Yu (W)

Department of Medicine, Hematology/Oncology, Goethe University Hospital, 60590 Frankfurt, Germany.

Mohamad Wessam Alnouri (MW)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany.

Sophie Ramas (S)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany.

Yang Zhang (Y)

Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule (ETH) Zurich, 4058 Basel, Switzerland.

Yannick Jäger (Y)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany.

Kenneth Anthony Roquid (KA)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany.

Hyun-Woo Jeong (HW)

Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, 48149 Münster, Germany.

Kishor Kumar Sivaraj (KK)

Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, 48149 Münster, Germany.

Haaglim Cho (H)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany.

Xinyi Chen (X)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany.

Boris Strilic (B)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany.

Tjeerd Sijmonsma (T)

Department of Medicine, Hematology/Oncology, Goethe University Hospital, 60590 Frankfurt, Germany.
German Cancer Consortium and German Cancer Research Center, Heidelberg, 69120, Germany.

Ralf Adams (R)

Department of Tissue Morphogenesis, Max Planck Institute for Molecular Biomedicine, 48149 Münster, Germany.

Timm Schroeder (T)

Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule (ETH) Zurich, 4058 Basel, Switzerland.

Michael A Rieger (MA)

Department of Medicine, Hematology/Oncology, Goethe University Hospital, 60590 Frankfurt, Germany.
German Cancer Consortium and German Cancer Research Center, Heidelberg, 69120, Germany.
Frankfurt Cancer Institute, 60590 Frankfurt, Germany.
Cardio-Pulmonary Institute, 60590 Frankfurt, Germany.

Stefan Offermanns (S)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany; remy.bonnavion@mpi-bn.mpg.de Stefan.Offermanns@mpi-bn.mpg.de.
Frankfurt Cancer Institute, 60590 Frankfurt, Germany.
Cardio-Pulmonary Institute, 60590 Frankfurt, Germany.
German Centre for Cardiovascular Research, Rhine-Main site, Frankfurt and Bad Nauheim, 60590, Germany.
Centre for Molecular Medicine, Medical Faculty, Goethe University Frankfurt, 60590 Frankfurt, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH